Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00686205 · ClinicalTrials.gov registry record · Phase 3
Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay
A Phase 3 study, sponsored by Abbott Diagnostics Division.
- Completed
- Registry status
- Phase 3
- Development phase
- 24,111
- Enrollment target
NCT00686205: Completed Phase 3 study, sponsored by Abbott Diagnostics Division.
NCT00686205 is a Phase 3 study that has completed, run by Abbott Diagnostics Division. The registered enrollment target is 24,111 participants, above the 770-participant average among 15,282 other Phase 3 trials with a reported enrollment target (3031% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00686205, a Phase 3 study, has completed, sponsored by Abbott Diagnostics Division.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 24,111 participants
- Enrollment target
Study Summary
To test blood samples from volunteer donors of whole blood and blood components using a new investigational test that detects human immunodeficiency virus (HIV) infection. Results will be compared to the current HIV screening assay.
Primary Outcome
Negative HIV status was determined by the results of the HIV-1/HIV-2 comparator assay and HIV-1 qualitatitve RNA.
Interventions
- DEVICE collection of follow-up sample based on PRISM HIV O Plus result
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24,111 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
What the finished NCT00686205 record still lists
NCT00686205 is an interventional study that assigns participants to a tested intervention. Its 24,111 participants enrollment target places it among the larger protocols in the corpus, above the 770-participant average among 15,282 other Phase 3 trials with a reported enrollment target (3031% higher).
The record links to 0 conditions, and to 1 intervention - of which collection of follow-up sample based on PRISM HIV O Plus result is the first listed.
NCT00686205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00686205 about?
NCT00686205 is a clinical study titled "Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay". To test blood samples from volunteer donors of whole blood and blood components using a new investigational test that detects human immunodeficiency virus (HIV) infection. Results will be compared to the current HIV screening assay.
What is the current status of trial NCT00686205?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 24,111 participants. The study started on 2007-08. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00686205?
The interventions under investigation include: collection of follow-up sample based on PRISM HIV O Plus result (DEVICE).
Who is sponsoring clinical trial NCT00686205?
This trial is sponsored by Abbott Diagnostics Division, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00686205's enrollment target sits among peer trials
24,111 9th of 2000 higher than 1,992 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06995898 · 24,000 participants · NA
The Vanguard Study: Testing a New Way to Screen for Cancer
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
- NCT06589310 · 25,000 participants
Falcon Real World Evidence Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia